Cremecomtrsbi Dl 001 Stock Return On Asset

WY52 Stock  EUR 1.70  0.00  0.00%   
CREMECOMTRSBI DL 001 fundamentals help investors to digest information that contributes to CREMETRSBI DL-001's financial success or failures. It also enables traders to predict the movement of CREMETRSBI Stock. The fundamental analysis module provides a way to measure CREMETRSBI DL-001's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CREMETRSBI DL-001 stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CREMECOMTRSBI DL 001 Company Return On Asset Analysis

CREMETRSBI DL-001's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current CREMETRSBI DL-001 Return On Asset

    
  0.0151  
Most of CREMETRSBI DL-001's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CREMECOMTRSBI DL 001 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, CREMECOMTRSBI DL 001 has a Return On Asset of 0.0151. This is 96.79% lower than that of the Real Estate sector and significantly higher than that of the REIT—Office industry. The return on asset for all Germany stocks is 110.79% lower than that of the firm.

CREMETRSBI Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CREMETRSBI DL-001's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CREMETRSBI DL-001 could also be used in its relative valuation, which is a method of valuing CREMETRSBI DL-001 by comparing valuation metrics of similar companies.
CREMECOMTRSBI is rated fifth in return on asset category among its peers.

CREMETRSBI Fundamentals

About CREMETRSBI DL-001 Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CREMECOMTRSBI DL 001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CREMETRSBI DL-001 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CREMECOMTRSBI DL 001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in CREMETRSBI Stock

CREMETRSBI DL-001 financial ratios help investors to determine whether CREMETRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMETRSBI with respect to the benefits of owning CREMETRSBI DL-001 security.